Background:
There is good evidence that diabetes is a risk factor for pulmonary tuberculosis. In England, the rates of both diabetes and tuberculosis vary markedly by ethnic group.
Objective:
To estimate the proportion of incident cases of pulmonary tuberculosis attributable to diabetes (population attributable fraction, PAF) for Asian, black and white men and women aged > or = 15 years in England.
Methods:
An epidemiological model was constructed using data on the incidence of tuberculosis, the prevalence of diabetes, the population structure for 2005 and the age-specific relative risk of tuberculosis associated with diabetes from a large cohort study.
Results:
The estimated PAF of diabetes for pulmonary tuberculosis is highest for Asian men (19.6%, 95% CI 10.9% to 33.1%) and women (14.2%, 95% CI 7.1% to 26.5%). The PAF for all ages is similar in white and black men (6.9%, 95% CI 3.1% to 12.4% and 7.4%, 95% CI 4.6% to 12.9%, respectively) and women (8.2%, 95% CI 3.0% to 15.6% and 8.9%, 95% CI 5.3% to 15.6%, respectively). The similarity of these overall figures, despite a higher prevalence of diabetes in the black population, reflects a much younger mean age of pulmonary tuberculosis in the black population. Overall, of 3461 new cases of pulmonary tuberculosis in England in 2005, 384 (202-780) were estimated to be attributable to diabetes.
Conclusion:
Given the nature of the data available, considerable uncertainty surrounds these estimates. Nonetheless, they highlight the potential importance of diabetes as a risk factor for pulmonary tuberculosis, particularly in groups at high risk of both diseases. Further research to examine the implications of these findings for tuberculosis control is urgently needed.
Citing Articles
Elderly Patients with Tuberculosis Combined with Diabetes Mellitus: A Comprehensive Analysis of Lymphocyte Subpopulation Dynamics, Clinical Features, Drug Resistance and Disease Regression.
Wang X, Song Y, Li N, Huo J, Wang B, Jiang X
Int J Gen Med. 2025; 18:1271-1282.
PMID: 40065980
PMC: 11892736.
DOI: 10.2147/IJGM.S502996.
Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective.
Ye Z, Li L, Yang L, Zhuang L, Aspatwar A, Wang L
Exploration (Beijing). 2024; 4(5):20230138.
PMID: 39439490
PMC: 11491313.
DOI: 10.1002/EXP.20230138.
Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries.
Abbas U, Masood K, Khan A, Irfan M, Saifullah N, Jamil B
J Clin Tuberc Other Mycobact Dis. 2022; 29:100343.
PMID: 36478777
PMC: 9720570.
DOI: 10.1016/j.jctube.2022.100343.
Engagement of private healthcare providers for case finding of tuberculosis and diabetes mellitus in Pakistan.
Habib S, Rafiq S, Jamal W, Ayub S, Ferrand R, Khan A
BMC Health Serv Res. 2020; 20(1):328.
PMID: 32306961
PMC: 7168982.
DOI: 10.1186/s12913-020-05217-2.
Opposite effects of statins on the risk of tuberculosis and herpes zoster in patients with diabetes: A population-based cohort study.
Pan S, Yen Y, Feng J, Chuang P, Su V, Kou Y
Br J Clin Pharmacol. 2019; 86(3):569-579.
PMID: 31633826
PMC: 7080625.
DOI: 10.1111/bcp.14142.
Analytical Exploration of Potential Pathways by which Diabetes Mellitus Impacts Tuberculosis Epidemiology.
Awad S, Dargham S, Omori R, Pearson F, Critchley J, Abu-Raddad L
Sci Rep. 2019; 9(1):8494.
PMID: 31186499
PMC: 6560095.
DOI: 10.1038/s41598-019-44916-7.
Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 1: Epidemiology and Clinical Management.
Critchley J, Restrepo B, Ronacher K, Kapur A, Bremer A, Schlesinger L
Chest. 2017; 152(1):165-173.
PMID: 28434936
PMC: 5989639.
DOI: 10.1016/j.chest.2017.04.155.
Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden.
Zheng C, Hu M, Gao F
Glob Health Action. 2017; 10(1):1-11.
PMID: 28245710
PMC: 5328328.
DOI: 10.1080/16549716.2016.1264702.
Association between diabetes and tuberculosis: case-control study.
Pereira S, Araujo G, de Souza Teles Santos C, Oliveira M, Barreto M
Rev Saude Publica. 2017; 50:82.
PMID: 28099656
PMC: 5152831.
DOI: 10.1590/S1518-8787.2016050006374.
Diabetes and Tuberculosis.
Restrepo B
Microbiol Spectr. 2017; 4(6).
PMID: 28084206
PMC: 5240796.
DOI: 10.1128/microbiolspec.TNMI7-0023-2016.
Risk for latent and active tuberculosis in Germany.
Herzmann C, Sotgiu G, Bellinger O, Diel R, Gerdes S, Goetsch U
Infection. 2016; 45(3):283-290.
PMID: 27866367
PMC: 5488071.
DOI: 10.1007/s15010-016-0963-2.
Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.
Diel R, Lampenius N, Nienhaus A
Pharmacoeconomics. 2015; 33(8):783-809.
PMID: 25774015
DOI: 10.1007/s40273-015-0267-x.
Tuberculosis and diabetes mellitus - an underappreciated association.
Skowronski M, Zozulinska-Ziolkiewicz D, Barinow-Wojewodzki A
Arch Med Sci. 2014; 10(5):1019-27.
PMID: 25395955
PMC: 4223145.
DOI: 10.5114/aoms.2014.46220.
Impact of diabetes on the natural history of tuberculosis.
Restrepo B, Schlesinger L
Diabetes Res Clin Pract. 2014; 106(2):191-9.
PMID: 25082309
PMC: 4260985.
DOI: 10.1016/j.diabres.2014.06.011.
Concomitant pulmonary tuberculosis in hospitalized healthcare-associated pneumonia in a tuberculosis endemic area: a multi-center retrospective study.
Feng J, Fang W, Wu C, Yu C, Lin M, Ku S
PLoS One. 2012; 7(5):e36832.
PMID: 22629334
PMC: 3358294.
DOI: 10.1371/journal.pone.0036832.